Rozšírené hľadanie
Sobota 30. November 2024 |
meniny má Ondrej, Andrej

Home | Mail Online 19.07.2024 04:45 Relugolix has been given the go-ahead on the NHS, potentially helping 40,000 men with advanced hormone sensitive prostate cancer.